IBIO = 1.09 US dollar
+0.0013 USD (+0.12%)
change of stock price since yesterday
Last deal stock price. Information on the stock quotation of the iBio, Inc. in US dollar is updated once a day. The stock quote price has an average value per day. 1 stock of iBio, Inc. is 1.09 US dollar. 1 stock of iBio, Inc. rises by 0.0013 US dollar. iBio, Inc. stock price rises since yesterday.
Show:
to
iBio, Inc. share price in US dollar
A month ago, iBio, Inc. stock could be sold for 0 US dollar. Six months ago, iBio, Inc. stock can be exchanged for 0 US dollar. Three years ago, iBio, Inc. stock could be bought for 1.35 US dollar. iBio, Inc. stock price in US dollar is convenient to see on the chart. 1.05% per week - the change in the stock price of iBio, Inc.. 0% per month - the change in the stock price of iBio, Inc..
Today, 10.91 US dollar is the price for 10 stocks of iBio, Inc.. You can exchange 25 stocks of iBio, Inc. for 27.28 US dollar. Stock quote converter now gives 54.57 US dollar for 50 stocks of iBio, Inc.. Stock quote converter now for 100 stocks of iBio, Inc. gives 109.13 US dollar. Stock quote converter today gives 272.83 US dollar for 250 stocks of iBio, Inc.. To buy 500 stocks of iBio, Inc., 545.65 US dollar are required.
IBIO stock price history
Date
Rate
Change
04/05/2023
1.09 USD
0.0013 ↑
03/05/2023
1.09 USD
-0.01 ↓
02/05/2023
1.1 USD
0.01 ↑
01/05/2023
1.09 USD
0.01 ↑
28/04/2023
1.08 USD
-
Today at 4 May 2023, 1 stock of iBio, Inc. costs 1.09 US dollar. iBio, Inc. stock price in US dollar on 3 May 2023 is equal to 1.09 US dollar. 2 May 2023, 1 stock of iBio, Inc. = 1.1 US dollar. 1 May 2023, 1 stock of iBio, Inc. costs 1.09 US dollar. iBio, Inc. stock price in US dollar on 28 April 2023 is equal to 1.08 US dollar.
iBio, Inc.
Today's stock price of iBio, Inc. is 1.09 $. IBIO stock price changed by +0.12% or +0.0013 USD since last trading day. You can buy 100 IBIO stocks for 109.13 US dollar or sell 50 IBIO stocks for 54.57 US dollar.
iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
